Results 181 to 190 of about 17,307 (223)

The diversity of AMPA receptor inhibition mechanisms among amidine-containing compounds. [PDF]

Front Pharmacol
Zhigulin AS, Dron MY, Barygin OI, Tikhonov DB.   +3 more
europepmc   +1 more source

Recent advances in structural modifications of natural products for anti-leishmaniasis therapy (2010-2024). [PDF]

RSC Med Chem
Sun FQ, Quan YS, Shen QK, Guo HY, Yin XM, Quan ZS.   +5 more
europepmc   +1 more source

Oral nanomedicines for the treatment of parasitic diseases [PDF]

, 2014
Dea Ayuela, Maria Auxiliadora, Lalatsa, Katerina, Serrano Lopez, Dolores Remedios, Smith, Lindsay   +3 more
core   +1 more source

Evaluation of sugar meal administered anti-Leishmania compounds on the vectorial capacity of the vector, Lutzomyia longipalpis. [PDF]

PLoS One
Ferreira TN, Latgé SGC, Ramos TD, Demidoff FC, Cunha-Júnior EF, Costa PRR, de Souza MVN, Brandão Gomes CR, Dillon VM, Netto CD, Torres Santos EC, Dillon RJ, McDowell MA, de Matos Guedes HL, Genta FA.   +14 more
europepmc   +1 more source

L'utilisation de la voie intramusculaire pour administrer l'iséthionate de pentamidine dans la leishmaniose cutanée à Leishmania guyanensis augmente le risque d'échec thérapeutique

, 2018
Jacques‐Robert Christen
openalex   +1 more source

Note sur un cas d'hémobartonellose canine en République Centrafricaine [PDF]

, 1970
Dupré, Jean-Jacques, Uilenberg, Gerrit
core  

Telomere biology disorder presented with de novo pneumocystis jirovecii pneumonia: A case report. [PDF]

Respir Med Case Rep
Hamad AK, Joudeh N, Saeed AM, Omar A, Ibraheem MK, Azar J.   +5 more
europepmc   +1 more source

1-Minute Pearls/Pitfalls for the Clinician. [PDF]

J Brown Hosp Med
Dapaah-Afriyie K, Gupta T, Hoffman P.
europepmc   +1 more source

From Abroad to Appalachia: A case report of cutaneous leishmaniasis in central Pennsylvania. [PDF]

JAAD Case Rep
Salmen N, Metellus R, Lim O, Pandya A, Horissian M.   +4 more
europepmc   +1 more source